Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: GLP Guideline study. According to ECHA guidance, a study with a read-across substance can have no reliability of higher than 2. The study itself is valid without restriction.
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
(adopted May 12, 1981)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Species:
guinea pig
Strain:
other: Pirbright White Strain (Tif: DHP)
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Ciba Geigy Ltd. Tierfarm, Sisseln, Switzerland
- Age at study initiation: no data
- Mean weight at study initiation: males = 382.7 g; females = 376.1 g
- Housing: housed individually in Macrolon cages (Type 3)
- Diet: ad libitum; standard guinea pig pellets -NAFAG No.847, Gossau SG (assayed for nutritive ingredients and contamination level by the manufacturer)
- Water: ad libitum (drinking water was examined periodically by the IWB (Industrielle Werke Basel)
- Acclimation period: 8 days
- Rationale for choice: The albino guinea pig is the recommended species for skin sensitization studies.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30-70
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
Route:
intradermal and epicutaneous
Vehicle:
other: Sesame oil (Intradermal induction), Vaseline (epicutaneous induction and challenge)
Concentration / amount:
Intradermal induction: 1%
epicutaneous induction: 30%
challenge: 3%
Route:
epicutaneous, occlusive
Vehicle:
other: Sesame oil (Intradermal induction), Vaseline (epicutaneous induction and challenge)
Concentration / amount:
Intradermal induction: 1%
epicutaneous induction: 30%
challenge: 3%
No. of animals per dose:
Test group : 20 animals
control group: 20 animals
Details on study design:
RANGE FINDING TESTS:
Separate animals were treated with the test article for the evaluation of the primary irritation threshold concentration. 10 % in Vaseline induced erythema reactions. 3 % in Vaseline did not induce skin reactions and, therefore, this concentration was used as the maximal sub-irritant concentration for the challenge applications.

MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal Injection
- Site/Area: Neck region/2 x 4 cm
- No. of injections/animal: 3 pairs
- Test substance group (cranial; 2 injections side by side): Freund's complete adjuvant (FCA) blended (1:1, v/v) with physiol. saline
- Test substance group (middle; 2 injections side by side): The test article (1%) in sesame oli
- Test substance group (caudal; 2 injections side by side): Freund's complete adjuvant blended (1:1, v/v) with physiol. saline + 1 % test article in vehicle.
- Control group (cranial; 2 injections side by side): Freund's complete adjuvant (FCA) blended (1:1, v/v) with physiol. saline
- Control group (middle; 2 injections side by side): Sesame oil
- Control group (caudal; 2 injections side by side): Freund's complete adjuvant blended (1:1, v/v) with physiol. saline + 1 % test article in vehicle.
- Volume per injection: 0.1 ml
- Evaluation (hr after injection): from 24 hour till day 7
- Exposure period: Single exposure

Epicutaneous induction exposure
- Time schedule: 1 week after intradermal injection
- Site: same site as intradermal injections
- Frequency of applications: Once.
- Area of application: 2 x 4 cm (filterpaper patch)
- Concentrations: 30% (test group), vehicle (control group)
- Amount applied: approx. 0.4 g paste of test substance in vaseline
- Type of coverage: occlusive
- Duration: 48 hours
- Evaluation (hr after challenge): directly after removal of patch

B. CHALLENGE EXPOSURE (all animals i.e treated animals and control animals)
- Time schedule: 2 weeks after termination of epicutaneous induction exposure
- Site: flank
- Area of application: 2 x 2 cm (filterpaper patch)
- Concentrations: 3%
- Amount applied: 0.2 g paste of test substance in vaseline (one flank) and vaseline (other flank)
- Type of coverage: occlusive
- Duration: 24 hours
- Evaluation (hr after challenge): 24 and 48 hours after termination of exposure

B.2. RECHALLENGE EXPOSURE
After the standard challenge exposures, 6 animals of the test group showed very slight skin reactions 24 and 48 hours. Because all the reactions observed were mild, a second challenge application was performed after a further period of 1 week.

SCORING SYSTEM: Draize in Appraisal of the Safety of chemicals in Foods, Drugs and Cosmetics (1959), The US Association of Food and Drug Officials (AFDO).
Erythema and eschar formation:
No erythema: 0
Very slight erythema (barely perceptible): 1
Well-defined erythema: 2
Moderate to severe erythema: 3
Severe erythema (beet redness) to slight eschar formation (injuries in depth): 4

Oedema formation:
No oedema: 0
Very slight edema (barely perceptible): 1
Slight edema (edges of area well defined by definite raising): 2
Moderate oedema (raised approximately 1 millimetre): 3
Severe oedema (raised more than 1 millimetre and extending beyond the area of exposure): 4
Positive control substance(s):
yes
Remarks:
The sensitivity of the assay was checked every six months with Paraphenylene-diamine or Potassium-dichromate
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
3%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 3%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
3%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 3%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
3%
No. with + reactions:
7
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 3%. No with. + reactions: 7.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
3%
No. with + reactions:
6
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 3%. No with. + reactions: 6.0. Total no. in groups: 20.0.
Reading:
rechallenge
Hours after challenge:
24
Group:
test chemical
Dose level:
3%
No. with + reactions:
1
Total no. in group:
20
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 3%. No with. + reactions: 1.0. Total no. in groups: 20.0.
Reading:
rechallenge
Hours after challenge:
48
Group:
test chemical
Dose level:
3%
No. with + reactions:
1
Total no. in group:
20
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 3%. No with. + reactions: 1.0. Total no. in groups: 20.0.

Average body weights at termination

- males = 656 g

- females = 526.1 g

Interpretation of results:
not sensitising
Remarks:
Migrated information
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:
Justification for selection of skin sensitisation endpoint:
The substance is considered to be non-sensiting to skin based on the minimal erythematous response (1/20 responders) observed at re-challenge in a guinea-pig M&K study with its close analogue.

Justification for classification or non-classification

Not classified for skin sensitisation, according to the criteria of CLP regulation EC No.1272/2008